The Senior Director will oversee systems and processes supporting electronic data capture (EDC), interactive response technology (IRT), electronic clinical outcome assessments (eCOA/ePRO), clinical data repositories, and related applications, partnering closely with Clinical Data Management, Statistical Programming, Biostatistics, Clinical Operations, Clinical Supply, Regulatory Affairs, Quality, IT, and third-party vendors. Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (Duchenne), Friedreich's ataxia (FA), catecholaminergic polymorphic ventricular tachycardia (CPVT), TNNT2-mediated dilated cardiomyopathy, BAG3-mediated dilated cardiomyopathy, and additional fatal, genetic cardiac diseases.